Cancer Patient Perspectives on Clinical Trial Discussion and Informed Consent Through Telemedicine
JCO Oncology Practice · 2025
DOI: 10.1200/op-24-00764 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Practice, 2025. Verfasst von Yasin Khadem Charvadeh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, New York, NY. Hauptthemen laut MEDLINE: Telemedicine, Informed Consent, Neoplasms, Clinical Trials as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE Clinical trials are integral for patients with cancer but remain inaccessible to many because of barriers including geographic and transportation challenges. This study aimed to evaluate cancer patients' preferences for telemedicine versus in-person visits for clinical trial discussions and informed consent (IC). METHODS An electronic survey was administered to first-time telemedicine users at Memorial Sloan Kettering Cancer Center from 2021 to 2023. The survey assessed patients' preferences for telemedicine versus in-person visits for the IC process and their comfort with discussing clinical trials virtually. The primary outcome was the proportion of patients who indicated that they preferred a telemedicine visit for the IC process. Patient comfort and preference for discussing clinical trials through telemedicine versus an in-person visit was also explored. Structured responses provided quantitative data over the 2021-2023 observation period and demographic variations. To gain a more detailed understanding, unstructured free-text responses describing clinical trial discussions were also analyzed through language modeling. RESULTS Overall, 57% of patients (540/955) preferred telemedicine, 26% (249/955) had no preference, and 17% (166/955) preferred in-person visits for the IC process. The preference for telemedicine remained consistent across the 2021-2023 observation period. Most patients reported no difference between a telemedicine versus in-person visit for clinical trial discussion, including asking questions, sharing concerns, declining participation, and asking for more time to make a decision. Language modeling analysis revealed areas for improvement. CONCLUSION A majority of patients at a comprehensive cancer center who participated in clinical trial discussions through telemedicine reported a preference for telemedicine to complete the IC process. Telemedicine thus represents a valuable tool for reducing barriers to clinical trial participation, particularly in reducing travel and time barriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Memorial Sloan Kettering Cancer Center, New York, NY.
- Weill Cornell Medical College, New York, NY.
ORCID-Profile: Yasin Khadem Charvadeh, Sahil D Doshi, Kenneth Seier, Erin M Bange, Bobby Daly, Allison Lipitz-Snyderman, Fernanda C G Polubriaginof, Michael Buckley, Gilad Kuperman, Peter D Stetson, Deb Schrag, Michael J Morris
Förderung
- NCI NIH HHS
Zitieren
APA
Khadem Charvadeh, Y., Doshi, S. D., Seier, K., Bange, E. M., Daly, B., Lipitz-Snyderman, A., Polubriaginof, F. C. G., Buckley, M., Kuperman, G., Stetson, P. D., Schrag, D., Morris, M. J., & Panageas, K. S. (2025). Cancer Patient Perspectives on Clinical Trial Discussion and Informed Consent Through Telemedicine. JCO Oncology Practice. https://doi.org/10.1200/op-24-00764
Vancouver
Khadem Charvadeh Y, Doshi SD, Seier K, Bange EM, Daly B, Lipitz-Snyderman A, et al. Cancer Patient Perspectives on Clinical Trial Discussion and Informed Consent Through Telemedicine. JCO Oncology Practice. 2025. doi:10.1200/op-24-00764
BibTeX
@article{KhademCharvadeh2025,
author = {Khadem Charvadeh, Yasin and Doshi, Sahil D and Seier, Kenneth and Bange, Erin M and Daly, Bobby and Lipitz-Snyderman, Allison and Polubriaginof, Fernanda C G and Buckley, Michael and Kuperman, Gilad and Stetson, Peter D and Schrag, Deb and Morris, Michael J and Panageas, Katherine S},
title = {Cancer Patient Perspectives on Clinical Trial Discussion and Informed Consent Through Telemedicine},
journal = {JCO Oncology Practice},
year = {2025},
doi = {10.1200/op-24-00764}
}
EUVIMED